Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Clinical Response in Relapsed/Refractory AML Patients Correlates with Leukemic Blast Mobilization and Differentiation Induced by BL-8040, A Potent CXCR4 Antagonist
6 September 2025
Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S
In clinical trials involving 17,183 patients, 50.2% of participants treated with GLP-1 receptor agonists lost at least 5% of their body weight, and 17.5% achieved a weight loss of 10% or more, both figures being significant compared to a placebo group
Semaglutide is given as a simple once-weekly injection under the skin
esculentum (Yamaguchi et al., 1995
US$ 21.76
US$ 20.50
US$ 28.17
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
